Table of Contents PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Cervical cancer diagnosis by HPV testing PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global HPV testing market by systems • Global HPV testing market by consumables PART 07: Market segmentation by end-user • Hospitals • Clinical diagnostic laboratories • Physicians' office laboratories PART 08: Geographical segmentation • HPV testing market in Americas • HPV testing market in EMEA • HPV testing market in APAC PART 09: Market drivers • Early detection of cervical cancer to prevent the growing prevalence • Paradigm shift toward use of HPV home-testing kits • Reimbursements for HPV tests PART 10: Impact of drivers PART 11: Market challenges • Pap test: Alternative diagnostic test for cervical cancer screening • Limited number of health clinics and healthcare settings in developing countries • Lack of uniformity in screening policies PART 12: Impact of drivers and challenges PART 13: Market trends • Expansion of companies in key markets • Co-testing with HPV and Pap tests • Development of mRNA HPV test PART 14: Vendor landscape • Competitive landscape analysis PART 15: Key vendor analysis • Abbott Laboratories • BD • Roche Diagnostics • Qiagen • Hologic • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Market dynamics: Global HPV testing market Exhibit 03: Global HPV testing market 2015-2020 ($ millions) Exhibit 04: Five forces analysis Exhibit 05: Global HPV testing market by product 2015 and 2020 Exhibit 06: Market overview: Global HPV testing market by systems Exhibit 07: Global HPV testing market by systems 2015-2020 ($ millions) Exhibit 08: PEST analysis: Global HPV testing market by systems Exhibit 09: Market overview: Global HPV testing market by consumables Exhibit 10: Global HPV testing market by consumables 2015-2020 ($ millions) Exhibit 11: PEST analysis: Global HPV testing market by consumables Exhibit 12: Global HPV testing market by end-users 2015 Exhibit 13: Revenue generated by diagnostic and medical laboratories in US 2009-2014 ($ millions) Exhibit 14: Global HPV testing market by geography in 2015 and 2020 ($ millions) Exhibit 15: Americas: Market overview of HPV testing Exhibit 16: Comparative percentage of women aged between 20 and 69 who participated in cervical cancer screening in Americas (2003 and 2013) Exhibit 17: HPV testing market in Americas 2015-2020 ($ millions) Exhibit 18: HPV testing market in Americas: Analysis in various countries Exhibit 19: Key takeaway: HPV testing market in the US Exhibit 20: PEST analysis: HPV testing market in the US Exhibit 21: Differences: HPV testing guidelines for cervical cancer testing Exhibit 22: EMEA: market overview of HPV testing Exhibit 23: Percentage of women aged 20-69 participated in cervical cancer screening in EMEA in different countries (2003 and 2013) Exhibit 24: HPV testing market in EMEA 2015-2020 ($ millions) Exhibit 25: HPV testing market in EMEA: Analysis in various countries Exhibit 26: Key takeaway: HPV testing market in the UK Exhibit 27: PEST analysis: HPV testing market in the UK Exhibit 28: APAC: market overview of HPV testing Exhibit 29: HPV testing market in APAC 2015-2020 ($ millions) Exhibit 30: HPV testing market in EMEA: Analysis in various countries Exhibit 31: Estimated number of cervical cancer in women at different age groups 2014 Exhibit 32: Market impact analysis: HPV home-testing kits Exhibit 33: Impact of drivers Exhibit 34: Lack of uniformity in cervical cancer screening intervals in EMEA Exhibit 35: Impact of drivers and challenges Exhibit 36: Market impact analysis: companies in key market Exhibit 37: Market analysis: Companies focusing on mRNA HPV test Exhibit 38: Competitive structure analysis of global HPV testing market 2015 Exhibit 39: Competitive landscape analysis of global HPV testing market 2015 Exhibit 40: Market penetration of various HPV testing manufacturing companies in global (2015) Exhibit 41: Game changing factors for companies to focus on the market Exhibit 42: Abbott Laboratories strength assessment Exhibit 43: Abbott Laboratories strategy assessment Exhibit 44: Abbott Laboratories opportunity assessment Exhibit 45: BD strength assessment Exhibit 46: BD strategy assessment Exhibit 47: BD opportunity assessment Exhibit 48: Roche Diagnostics strength assessment Exhibit 49: Roche Diagnostics strategy assessment Exhibit 50: Roche Diagnostics opportunity assessment Exhibit 51: Qiagen strength assessment Exhibit 52: Qiagen strategy assessment Exhibit 53: Qiagen opportunity assessment Exhibit 54: Hologic strength assessment Exhibit 55: Hologic strategy assessment Exhibit 56: Hologic opportunity assessment Exhibit 57: Other prominent vendors Exhibit 58: Product matrix: HPV testing market analysis

Abbott Laboratories, BD, Roche Diagnostics, Qiagen, Arbor Vita, Breakspear Medical, Cepheid, DAAN Gene, DiaCarta, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, Seegene, SoloPap, Trovagene.